Catalyst Wire Dossier Catalyst Wire Dossier

Pralubactam

pralubactam · Qilu Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pralubactam, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections [Phase 3]

See pricing